IL28B Alleles Exert an Additive Dose Effect When Applied to HCV-HIV Coinfected Persons Undergoing Peginterferon and Ribavirin Therapy

• Barham K. Abu Dayyeh,

  Affiliations Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Namrata Gupta,

  Affiliation Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

  ⨯
• Kenneth E. Sherman,

  Affiliation Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
• Paul I. W. de Bakker,

  Affiliations Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands, Division of Biomedical Genetics, Department of Medical Genetics, University Medical Center, Utrecht, The Netherlands

  ⨯
• Raymond T. Chung ,

  * E-mail: rtchung@partners.org

  Affiliations Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• for the Aids Clinical Trials Group A5178 Study Team